DrugPatentWatch Database Preview
Amgen Company Profile
What is the competitive landscape for AMGEN, and when can generic versions of AMGEN drugs launch?
AMGEN has two approved drugs.
There are seven US patents protecting AMGEN drugs.
There are two hundred and thirty-six patent family members on AMGEN drugs in fifty countries and seven supplementary protection certificates in seven countries.
Summary for Amgen
International Patents: | 236 |
US Patents: | 7 |
Tradenames: | 2 |
Ingredients: | 2 |
NDAs: | 2 |
Patent Litigation for Amgen: | See patent lawsuits for Amgen |
PTAB Cases with Amgen as patent owner: | See PTAB cases with Amgen as patent owner |
Drugs and US Patents for Amgen
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amgen Inc | CORLANOR | ivabradine hydrochloride | TABLET;ORAL | 206143-002 | Apr 15, 2015 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
Amgen | SENSIPAR | cinacalcet hydrochloride | TABLET;ORAL | 021688-003 | Mar 8, 2004 | AB | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
Amgen Inc | CORLANOR | ivabradine hydrochloride | TABLET;ORAL | 206143-001 | Apr 15, 2015 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
Amgen Inc | CORLANOR | ivabradine hydrochloride | TABLET;ORAL | 206143-001 | Apr 15, 2015 | RX | Yes | No | 7,361,649 | ➤ Try a Free Trial | Y | Y | ➤ Try a Free Trial | ||
Amgen | SENSIPAR | cinacalcet hydrochloride | TABLET;ORAL | 021688-001 | Mar 8, 2004 | AB | RX | Yes | No | 6,011,068 | ➤ Try a Free Trial | Y | Y | ➤ Try a Free Trial | |
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Amgen
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Amgen | SENSIPAR | cinacalcet hydrochloride | TABLET;ORAL | 021688-002 | Mar 8, 2004 | 6,031,003 | ➤ Try a Free Trial |
Amgen | SENSIPAR | cinacalcet hydrochloride | TABLET;ORAL | 021688-001 | Mar 8, 2004 | 6,011,068 | ➤ Try a Free Trial |
Amgen | SENSIPAR | cinacalcet hydrochloride | TABLET;ORAL | 021688-001 | Mar 8, 2004 | 6,313,146 | ➤ Try a Free Trial |
Amgen | SENSIPAR | cinacalcet hydrochloride | TABLET;ORAL | 021688-003 | Mar 8, 2004 | 6,313,146 | ➤ Try a Free Trial |
Amgen | SENSIPAR | cinacalcet hydrochloride | TABLET;ORAL | 021688-002 | Mar 8, 2004 | 6,313,146 | ➤ Try a Free Trial |
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for AMGEN drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Tablets | 30 mg, 60 mg and 90mg | ➤ Subscribe | 2008-03-10 |
International Patents for Amgen Drugs
Country | Document Number | Estimated Expiration |
---|---|---|
Brazil | PI0600623 | ➤ Try a Free Trial |
European Patent Office | 1296142 | ➤ Try a Free Trial |
Spain | 2313581 | ➤ Try a Free Trial |
Denmark | 2821067 | ➤ Try a Free Trial |
Costa Rica | 8248 | ➤ Try a Free Trial |
Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Amgen Drugs
Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|
2005 00027 | Denmark | ➤ Try a Free Trial | |
1203761/01 | Switzerland | ➤ Try a Free Trial | PRODUCT NAME: CINACALCETUM; REGISTRATION NUMBER/DATE: SWISSMEDIC 56965 27.10.2004 |
182 | Luxembourg | ➤ Try a Free Trial | 91182, EXPIRES: 20191022 |
C0029 | France | ➤ Try a Free Trial | PRODUCT NAME: CINACALCET; REGISTRATION NO/DATE: EU/01/04/292/001-012 20041022 |
0199 | Netherlands | ➤ Try a Free Trial | |
Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |